Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Registrati

Quotazioni in diretta

BLFS BioLife Solutions Inc

23,40

0,00 (0,00%)

Pre Mercato

Ultimo aggiornamento: 09:30:00

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares to be sold were acquired between 1/1/2022 and 8/1/2022 upon the vesting of restricted stock awards.

Date of Notice

08/19/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Joseph Schick

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni BioLife Solutions (NASDAQ:BLFS)
Storico
Da Ott 2024 a Nov 2024

Clicca qui per i Grafici di BioLife Solutions

Grafico Azioni BioLife Solutions (NASDAQ:BLFS)
Storico
Da Nov 2023 a Nov 2024

Clicca qui per i Grafici di BioLife Solutions

Notizie BioLife Solutions Inc - BLFS

BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024
Giovedì 31 Ottobre 2024 (14 ore fa) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 18 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 20 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 18 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 18 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 18 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 18 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 18 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 18 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercoledì 18 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunedì 19 Agosto 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Venerdì 9 Agosto 2024 (3 mesi fa) • Edgar (US Regulatory)

Più BioLife Solutions Inc Articoli Notizie

DIFF28F33 - 01/2028

Opportunistic Trader ETF

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea